Kailera Therapeutics Raises $718.8 Million in IPO, Begins Trading on Nasdaq
Kailera Therapeutics completed an initial public offering that generated $718.8 million in gross proceeds by selling 44,921,875 common shares at $16.00 apiece. The offering included the full exercise of an underwriters' option for 5,859,375 extra shares. Kailera began trading on the Nasdaq Global Select Market under the ticker KLRA and is developin…